|
0
|
|
RNF126 is a peroxisomal fate switch enabling redifferentiation therapy in hepatocellular carcinoma.
(pnas.org)
|
Su Q
…
Zhang Y
PNAS
2026-06-16
|
#hepatocellular carcinoma
#hypoxia
#autophagy
#metabolism
#differentiation
|
|
0
|
|
Immune Checkpoint Inhibitor-Induced Rapid Decline in Hepatitis B Virus Markers Improves the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients.
(academic.oup.com)
|
Ran Y
…
Fan R
Journal of Infectious Diseases
2026-06-16
|
#hepatocellular carcinoma
#hepatitis b
#immunotherapy
#viremia
#prognosis
|
|
0
|
|
Targeting NEK9 synergises with immunotherapy in hepatocellular carcinoma by remodelling the immunosuppressive microenvironment.
(gut.bmj.com)
|
Lu G
…
Shang Y
Gut
2026-06-25
|
#immunotherapy
#hepatocellular carcinoma
#immunosuppression
#kinase inhibition
#single-cell sequencing
|
|
0
|
|
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.
(gut.bmj.com)
|
Xiang YJ
…
Cheng SQ
Gut
2026-07-03
|
#hepatocellular carcinoma
#diabetes
#recurrence
#pharmacotherapy
#survival
|
|
0
|
|
XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Wang W
…
Wang C
Cell Chemical Biology
2026-07-07
|
#hepatocellular carcinoma
#oxidative stress
#drug-repurposing
#crispr screening
#combination therapy
|
|
0
|
|
Outcome scoring systems for locoregional therapy in hepatocellular carcinoma: a systematic review.
(gut.bmj.com)
|
Daruwalla C
…
Hernaez R
Gut
2026-07-09
|
#hepatocellular carcinoma
#prognostication
#locoregional-therapy
#systematic review
#prediction-models
|
|
0
|
|
Prediction of microvascular invasion in hepatocellular carcinoma using contrast-enhanced ultrasound and deep learning.
(nature.com)
|
Pang C
…
Liang P
Nature Communications
2026-07-10
|
#hepatocellular carcinoma
#deep learning
#imaging
#prognosis
#immunotherapy
|
|
0
|
|
Polyvinyl chloride promotes radioresistance in hepatocellular carcinoma by inhibiting radiotherapy-induced CD8(+) T cell differentiation.
(nature.com)
|
Zhang H
…
Sheng H
Nature Communications
2026-07-10
|
#radiotherapy
#hepatocellular carcinoma
#immunotherapy
#cholesterol metabolism
#t cell differentiation
|